Navigation Links
STEP™ Instruments (100 mm Working Length)

ProductsSTEP™ Instruments (100 mm Working Length)
Company Autosuture
Item STEP™ Instruments (100 mm Working Length)
Features 
  • Single use system
  • Sterile
  • Available in five sizes
  • Packaged in various configurations and combinations
  • Used in conjunction with the Step™ Insufflation and Access needle and the Step™ radially Expandable Sleeve
  • 5, 7/8, 10 and 12 mm cannula include a reducer cap
  • 10 units per box
    • Description The Step™ and Mini Step™ device components are supplied sterile.

    The Step™ and Mini Step™ Single Use System is supplied sterile in 2/3, 5, 7/8, 10 and 12 mm sizes, packaged in various configurations and combinations. They are used in conjunction with the Step™ Insufflation and Access needle and the Step™ radially Expandable Sleeve. The 5, 7/8, 10 and 12 mm cannula include a reducer cap which allows the insertion of instruments smaller than the cannula diameter.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. STEP™ and STEP™ Short Reducers
    2. STEP™ Short Instruments
    3. VERSASTEP™ Reposable Sterilization Trays
    4. VERSASTEP™ Reposable Single Use Instruments
    5. Williams Micro Discectomy Instruments
    6. Spinal Instruments
    7. Moss Intradiscal Instruments
    8. PLIG (Posterior Lumbar Interbody Graft) Instruments
    9. TLIF Instruments
    10. T.L.I.F. SG Instruments
    11. Genesis II Patellar Instruments
    Breaking Medicine Technology:Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2IPY follow up requires year round research on Arctic and global warming 9894 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 1Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 2Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 3Calixa Therapeutics to Make Multiple Presentations on CXA 101 and CXA 101 tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agent 4978 4Schofield Media Names Brian Reshefsky Group President 56972 1